This review addresses progress in recent years in the study of antitumor antibiotics of the aureolic acid group.
Similar content being viewed by others
References
U. Hollstein, Chem. Rev., 74(6), 625 – 652 (1974).
S. A. Waksman and H. B. Woodruff, Proc. Soc. Exper. Biol., 45, 609 – 614 (1940).
R. C. Lynch and B. C. Medeiros, Expert Opin. Pharmacother., 16(14), 2149 – 2162 (2015).
Q. Gong, L. Zhou, S. Xu, et al., PLoS One, 10(5), e01256122015 (2015).
G. Minotti, P. Menna, E. Salvatorelli, et al., Pharmacol. Rev., 56(2), 185 – 229 (2004).
G. H. Oliveira, S. G. Al-Kindi, P. F. Caimi, and H. M. Lazarus, Blood Rev., 30(3), 169 – 178 (2016).
H. J. Röthig, H. P. Kraemer, and H. H. Sedlacek, Drugs Exp. Clin. Res., 11(2), 123 – 125 (1985).
G. Wei, W. Ni, J. W. Chiao, et al., J. Hematol Oncol., 4, 46 (2011).
L. M. Hollingshead and D. Faulds, Drugs, 42(4), 690 – 719 (1991).
X. Li, S. Xu, Y. Tan, and J. Chen, Cochrane Database Syst. Rev., 6, CD010432 (2015) (doi: 10.1002 / 14651858. CD010432.pub2).
R. J. Cersosimo and W. K. Hong, J. Clin. Oncol., 4(3), 425 – 439 (1986).
N. Yamaguchi, T. Fujii, S. Aoi, et al., Eur. J. Cancer, 51(16), 2314 – 2320 (2015).
D. Ogawara, M. Fukuda, Y. Nakamura, and S. Kohno, Cancer Manag. Res., 11(2), 191 – 195 (2010).
Q. Ding J. Zhan, Drug Des. Devel. Ther., 7, 681 – 689 (2013).
J. Chen and J. Stubbe, Nature Rev. Cancer, 5(2), 102 – 112 (2005).
L. Kruter, V. Saggar, A. Akhavan, et el., J. Cutan. Med. Surg., 19(5), 470 – 476 (2015).
H. M. Sobell, Proc. Nat. Acad. Sci. USA, 82(16), 5328 – 5331 (1985).
M. S. Weaver, F. Navid, A. Huppmann, et al., J. Pediatr. Hematol. Oncol., 37(3), 237 – 241 (2015).
N. Osada, Y. Kosuge, K. Ishige, and Y. Ito, J. Pharmacol. Sci., 122(4), 251 – 256 (2013).
W. T. Bradner, Cancer Treat. Rev., 27(1), 35 – 50 (2001).
F. Zagouri, T. N. Sergentanis, D. Chrysikos, et al., Onco Targets Ther., 8, 2187 – 2198 (2015).
S. Forli, Cur. Top. Med. Chem., 14(20), 2313 – 2321 (2014).
C. F. Brogdon, F. Y. Lee, and R. M. Canetta, Anticancer Drugs, 25(5), 599 – 609 (2014).
M. B. Atkins, U. Yasothan, and P. Kirkpatrick, Nature Rev. Drug Discovery, 8, 535 – 536 (2009).
M. E. Royce and D. Osman, Breast Cancer (Auckl.), 9, 73 – 79 (2015).
U. Saran, and M. Foti, and J. F. Dufour, Clin. Sci. (Lond.), 129(10), 895 – 914 (2015).
F. Lombo, N. Menendez, J. A. Salas, and C. Mendez, Appl. Microbiol. Biotechnol., 73(1), 1 – 14 (2006).
V. T. J. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles & Practice of Oncology, Lippincott Williams &Wilkins, Philadelphia (2005).
M. Ogawa, Antibiot. Chemother., 24, 149 – 159 (1978).
G. F. Gause, in: Handbook of Experimental Pharmacology., A. C. Sartorelli (ed.), Springer-Verlag Berlin, Heidelberg, New York (1975), pp. 615 – 622.
K. X. Chen, N. Gresh, X. Hui, et al., FEBS Letters, 245(1 – 2), 145 – 149 (1989).
C. Méndez, J. González-Sabín, F. Morís, and J. A. Salas, Planta Med., 81(15), 1326 – 1338 (2015).
C. Vizcanío, S. Mansilla, and J. Portugal, Pharmacol. Ther., 152, 111 – 124 (2015).
K. Deacon, D. Onion, R. Kumari, et al., J. Biol. Chem., 287(47), 39967 – 39981 (2012).
S. Safe, P. Imanirad, S. Sreevalsan, et al., Expert Opin. Ther. Targets, 18(7), 759 – 769 (2014).
K. Beishline and J. Azizkhan-Clifford, FEBS J., 282(2), 224 – 258 (2015).
D. Hanahan and R. A. Weinberg, Cell, 144(5), 646 – 674 (2011).
S. Boichuk, D. J. Lee, K. R. Mehalek, et al., Cancer Res., 74(4), 1200 – 1213 (2014).
K. Søreide, O. M. Sandvik, J. A. Søreide, et al., Cancer Epidemiol., 40, 39 – 46 (2015).
G. Demetri, in: Cancer: Principles and Practice of Oncology, DeVita, and Hellman, Rosenberg (eds.), New York (2011).
R. J. Vanner, M. Remke, M. Gallo, et al., Cancer Cell, 26(1), 33 – 47 (2014).
D. E. Tufcea and P. François, Biophys. J., 109(8), 1724 – 1734 (2015).
S. Liebner and K. H. Plate, J. Angiogenes. Res., 2(1), 1 (2010).
Y. H. Wang, X. M. Sui, Y. N. Sui, et al., Oncol. Let., 10(4), 2227 – 2232 (2015).
X. Huo, S. Li, T. Shi, et al., Biochem. Biophys. Res. Commun., 460(4), 1021 – 1028 (2015).
S. Saha, S. Mukherjee, M. Mazumdar, et al., Transl. Res., 165(5), 558 – 577 (2015).
B. Shcheglov, Nauka i Zhizn’, No. 8 (2013).
A. Borah, S. Raveendran, A. Rochani, et al., Oncogenesis, 4, e177 (2015).
M. Girlovanu, S. Susman, O. Soritau, et al., Clujul. Med., 88(3), 265 – 271 (2015).
M. A. Mir, S. Majee, S. Das, and D. Dasgupta, Bioorg. Med. Chem., 11(13), 2791 – 2801 (2003).
M. Tagashira, T. Kitagawa, S. Isonishi, et al., Biol. Pharm. Bul., 23(8), 926 – 929 (2000).
N. Montazami, and M. Aghapour, S. Farajnia, and B. Baradaran, Cell Mol. Biol. (Noisy-le-grand), 61, 70 – 80 (2015).
O. A. Fajardo, K. Thompson, S. K. Parapuram, et al., Cell Prolif., 44(2), 166 – 173 (2011).
P. J. Grohar, G. M. Woldemichael, L. B. Griffin, et al., J. Natl. Cancer Inst., 103(12), 962 – 978 (2011).
S. L. Lessnick, B. S. Braun, C. T. Denny, and W. A. May, Oncogene, 10(3), 423 – 431 (1995).
M. Zhang, A. Mathur, Y. Zhang, et al., Cancer Res., 72, 4178 – 4192 (2012).
J. González-Sabín and F. Morís, Biochem. Pharmacol., 2, No. 1, 1 – 3 (2013).
R. J. Ferrante, H. Ryu, J. K. Kubilus, et al., J. Neuroscience, 24, No. 46, 10335 – 10342 (2004).
P. D. Sutphin, D. A. Chan, J. M. Li, et al., Cancer Res., 67(12), 5896 – 5905 (2007).
Z. Jia, Y. Gao, L. Wang, et al., Cancer Res., 70(3), 1111 – 1119 (2010).
H. Hagiwara, M. Iyo, and K. Hashimoto, Brain Res., 1301, 189 – 196 (2009).
C. Olano, C. Mendez, and A. Salas, Nat. Prod. Rep., 26(5), 628 – 660 (2009).
N. Menendez, M. Nur-e-Alam, A. F. Brana, et al., Molec. Microbiol., 53(3), 903 – 915 (2004).
L. L. Remsing, J. Garcia-Bernardo, A. Gonzalez, et al., J. Am. Chem. Soc., 124(8), 1601 – 1614 (2002).
I. Baig, A. F. Braña, R. Gomathinayagam, et al., J. Nat. Prod., 71(2), 199 – 207 (2008).
M. Perez, I. Baig, A. F. Braña, et al., Chembiochem., 9(14), 2295 – 2304 (2008).
L. E. Núñez, S. E. Nybo, J. González-Sabón, et al., J. Med. Chem., 55(12), 5813 – 5825 (2012).
M. J. Lozano, L. L. Remsing, L. M. Quirós, et al., J. Biol. Chem., 275(5), 3065 – 3074 (2000).
G. Blanco, E. Fernández, M. J. Fernández, et al., Mol. Gen. Genet., 262(2), 991 – 1000 (2000).
G. Wang, P. Pahari, M. K. Kharel, et al., Angew. Chem. Int. Ed. Engl., 51(42), 10638 – 10642 (2012).
V. Kumar and W. A. Remers, J. Med. Chem., 23(4), 376 – 379 (1980).
Y. Kaziro and M. Kaiyama, J. Biochem., 62(4), 424 – 429 (1967).
W. R. Roush, R. A. Hartz, and D. J. Gustin, J. Am. Chem. Soc., 121(9), 1990 – 1991 (1999).
A. N. Tevyashova, Author’s Abstract of Doctoral Thesis, Moscow (2015).
L. L. Remsing, A. M. Gonzalez, M. Nur-e-Alam, et al., J. Am. Chem. Soc., 125(19), 5745 – 5753 (2003).
F. Barcelo, and M. Ortiz-Lombardéa, M. Martorell, et al., Biochemistry, 49(49), 10543 – 10552 (2010).
N. Menendez, M. Nur-e-Alam, A. F. Brana, et al., Chem. Biol., 11(1), 21 – 32 (2004).
A. N. Tevyashova, E. N. Olsufyeva, J. N. Balzarini, et al., J. Antibiotics, 62, 37 – 41 (2009).
Patent RF No. 2350621, Byul. Izobret., No. 9 (2009).
A. N. Tevyashova, A. A. Shtil, E. N. Olsufyeva, et al., Bioorg. Med. Chem., 19(24), 7387 – 7393 (2011).
A. N. Tevyashova, E. N. Olsufyeva, K. F. Turchin, et al., Bioorg. Med. Chem., 17(14), 4961 – 4967 (2009).
A. N. Tevyashova, N. A. Durandin, A. M. Vinogradov, et al., J. Antibiotics, 66(9), 523 – 530 (2013).
H. Chakraborty, P. D. Grihanjali, M. Sarkar, and D. Dasgupta, Rec. Advances Med. Chem., 1, 3 – 55 (2014).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 50, No. 7, pp. 3 – 8, July, 2016.
Rights and permissions
About this article
Cite this article
Tevyashova, A.N. Olivomycin A – an Antitumor Antibiotic of the Aureolic Acid Group (Review). Pharm Chem J 50, 425–430 (2016). https://doi.org/10.1007/s11094-016-1463-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-016-1463-5